Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients | Zendy

Noémi Pávó | Zendy; Markus Raderer | Zendy; Georg Goliasch | Zendy; Raphael Wurm | Zendy; Guido Strunk | Zendy; Anna Cho | Zendy; J Novák | Zendy; Heinz Gisslinger | Zendy; Günther Steger | Zendy; Michael Hejna | Zendy; Wolfgang J. Köstler | Zendy; Sabine ZöchbauerMüller | Zendy; Christine Marosi | Zendy; Gabriela Kornek | Zendy; Leo Auerbach | Zendy; Sven Schneider | Zendy; Bernhard Parschalk | Zendy; Werner Scheithauer | Zendy; Robert Pirker | Zendy; Barbara Kiesewetter | Zendy; Richard Pacher | Zendy; Christoph Zielinski | Zendy; Martin Hülsmann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients

Author(s) -

Noémi Pávó,

Markus Raderer,

Georg Goliasch,

Raphael Wurm,

Guido Strunk,

Anna Cho,

J Novák,

Heinz Gisslinger,

Günther Steger,

Michael Hejna,

Wolfgang J. Köstler,

Sabine ZöchbauerMüller,

Christine Marosi,

Gabriela Kornek,

Leo Auerbach,

Sven Schneider,

Bernhard Parschalk,

Werner Scheithauer,

Robert Pirker,

Barbara Kiesewetter,

Richard Pacher,

Christoph Zielinski,

Martin Hülsmann

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.17131

Subject(s) - medicine , cancer , bilirubin , gastroenterology

Routinely tested liver biomarkers as alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyltransferase (GGT), butyryl-cholinesterase (BChE), albumin and bilirubin are altered in distinct malignancies and hepatic metastases. This study aimed to investigate whether all liver parameters have the ability to predict long-term mortality in treatment naïve cancer patients but without a malignant hepatic involvement.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research